Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system available to radiation oncology professionals across the United States. Evo ...
This article was automatically generated by Dow Jones using technology from Automated Insights. Stocks in the Nordic region gained Wednesday, with the OMX Nordic 40 Index rising 1.5%. Elekta AB Series ...
(RTTNews) - Elekta AB (EKTA-B.ST), a Swedish medical technology company, on Monday announced that Chief Financial Officer Tobias Hägglöv is leaving the company after a transition period. The company ...
EYSINS, Switzerland, Sept. 3, 2025 /PRNewswire/ -- AliveDx, the global in-vitro diagnostics company that aims to transform patient care, today announces that it has submitted 510(k) premarket ...
EYSINS, Switzerland, Sept. 3, 2025 /PRNewswire/ -- AliveDx, the global in-vitro diagnostics company that aims to transform patient care, today announces that it has submitted 510 (k) premarket ...
AliveDx achieves IVDR-CE Mark for a multiplexed MosaiQ AiPlex ® Vasculitis (VAS) assay, designed to advance the testing of Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides and ...
Epic’s Beacon oncology module leads the way in customer satisfaction among EHR solutions for cancer care, KLAS Research reported July 10. Here are the top EHR solutions for oncology by performance ...
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. The IAEA and UK social enterprise MedAccess have launched ...
This prospective quality improvement study was conducted at the RT unit of King Faisal Specialist Hospital and Research Centre and King Abdulaziz University Hospital, Jeddah, Saudi Arabia, from ...
Swedish precision radiation therapy devices and software maker Elekta is bringing in an executive from Denmark to be its new CEO. Elekta today announced the appointment of Jakob Just-Bomholt, who will ...
Hi, and good morning, everyone. And welcome to this Conference Call for our Third Quarter. My name is Peter Nyquist, and I’m the head of Investor Relations here at Elekta. With me here in Stockholm at ...
PITTSBURGH — At 72, Ron Jesiolowski isn’t slowing down. Known for his art and resilience, the cancer survivor’s studio is filled with decades of work — but one piece still sits upon his easel. “I call ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results